Fortress Biotech posts 2026 shareholder vote results
Fortress Biotech reported the results of its 2026 annual meeting of stockholders held virtually on June 17.
Rhea-AI Filing Summary
Fortress Biotech reported the results of its 2026 annual meeting of stockholders held virtually on June 17. Stockholders voted on electing seven directors to serve until the 2027 meeting and on ratifying KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.
Each director nominee, including Lindsay A. Rosenwald, Jimmie Harvey Jr., Malcolm Hoenlein, Dov Klein, J. Jay Lobell, Kevin L. Lorenz, and Michael S. Weiss, received more votes "For" than "Against." The proposal to ratify KPMG LLP also received substantially more votes "For" than "Against," based on the reported vote totals.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Rosenwald: 11,022,326 votes
Votes for Jimmie Harvey Jr.: 10,322,230 votes
Total votes per director: 12,897,124 votes
+3 more
6 metrics
Votes for Rosenwald
11,022,326 votes
Director Lindsay A. Rosenwald election at 2026 annual meeting
Votes for Jimmie Harvey Jr.
10,322,230 votes
Director election at 2026 annual meeting
Total votes per director
12,897,124 votes
Total votes including broker non-votes for each director nominee
Votes for KPMG ratification
23,095,864 votes
Proposal to ratify KPMG LLP for year ending December 31, 2026
Votes against KPMG ratification
753,612 votes
Auditor ratification proposal at 2026 annual meeting
Abstentions on KPMG ratification
341,934 votes
Auditor ratification proposal at 2026 annual meeting
Key Terms
annual meeting of stockholders, independent registered public accounting firm, broker non-votes, definitive proxy statement
4 terms
annual meeting of stockholders financial
"held its annual meeting of stockholders (the “2026 Annual Meeting”)"
independent registered public accounting firm financial
"the ratification of the appointment of KPMG LLP as Fortress’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
broker non-votes financial
"Total Votes ... Broker Non-"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
definitive proxy statement regulatory
"The proposals are described in detail in the Company’s definitive proxy statement on Schedule 14A"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Fortress Biotech (FBIO) vote on at the 2026 annual meeting?
Fortress Biotech stockholders voted on two items: electing seven directors to serve until the 2027 annual meeting and ratifying KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026, as described in the company’s definitive proxy statement.
Were Fortress Biotech’s director nominees supported by stockholders at the 2026 meeting?
All seven director nominees received more votes "For" than "Against." For example, Lindsay A. Rosenwald received 11,022,326 votes for versus 239,772 against, while other nominees showed similar patterns of support based on the reported voting results in the meeting disclosure.
How did Fortress Biotech (FBIO) stockholders vote on the KPMG LLP auditor ratification?
Stockholders cast 23,095,864 votes "For" ratifying KPMG LLP as independent registered accounting firm, compared with 753,612 votes "Against" and 341,934 abstentions. The "For" votes substantially exceeded votes against, indicating strong support for retaining KPMG LLP for the 2026 fiscal year audit.
How many total votes were recorded for Fortress Biotech’s director elections?
For each director nominee, total votes reported were 12,897,124 including broker non-votes. Within this total, each nominee, such as Michael S. Weiss and Lindsay A. Rosenwald, received a majority of votes "For" compared with votes "Against" and abstentions in the tabulated results.
When and how was the 2026 Fortress Biotech annual meeting held?
The 2026 annual meeting of Fortress Biotech stockholders took place on June 17, 2026, at 10:00 a.m. Eastern Time. It was conducted as an online virtual meeting, allowing shareholders to participate and vote through a virtual meeting platform rather than an in-person gathering.
AI-generated analysis. How Rhea-AI works. Not financial advice.
